We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.49B
AUM Growth
-$90.6M
Cap. Flow
-$54.8M
Cap. Flow %
-3.67%
Top 10 Hldgs %
29.45%
Holding
140
New
5
Increased
31
Reduced
71
Closed
10

Top Buys

Rank Stock Value
1
RGEN icon
Repligen
RGEN
+$18.6M
2
LGND icon
Ligand Pharmaceuticals
LGND
+$15.9M
3
CMD
Cantel Medical Corporation
CMD
+$15.1M
4
MLAB icon
Mesa Laboratories
MLAB
+$4.76M
5
DORM icon
Dorman Products
DORM
+$2.99M

Top Sells

Rank Stock Value
1
HITT
HITTITE MICROWAVE CORP
HITT
+$26.4M
2
ABAX
Abaxis Inc
ABAX
+$14.2M
3
FARO
Faro Technologies
FARO
+$13.7M
4
BCPC
Balchem Corp
BCPC
+$7.13M
5
ALGN icon
Align Technology
ALGN
+$4.3M

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Healthcare 20.07%
3 Industrials 15.68%
4 Materials 8.38%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
51
ExxonMobil
XOM
$643B
$2.14M 0.14%
21,263
-20,515
-49% -$2.07M
TRMB icon
52
Trimble
TRMB
$13.5B
$797K 0.05%
21,565
-58,300
-73% -$2.18M
UNP icon
53
Union Pacific
UNP
$173B
$758K 0.05%
7,600
– –
GRMN
54
Garmin
GRMN
$58.8B
$666K 0.04%
10,940
– –
MKL icon
55
Markel Group
MKL
$23.3B
$659K 0.04%
1,005
-3,020
-75% -$1.9M
MYGN icon
56
Myriad Genetics
MYGN
$285M
$625K 0.04%
16,050
– –
ABBV icon
57
AbbVie
ABBV
$433B
$589K 0.04%
10,440
– –
PII icon
58
Polaris
PII
$4.02B
$555K 0.04%
4,260
-13,500
-76% -$1.79M
CVX icon
59
Chevron
CVX
$385B
$551K 0.04%
4,224
– –
VRSK icon
60
Verisk Analytics
VRSK
$25.1B
$546K 0.04%
9,105
-50
-0.5% -$2.99K
JNJ icon
61
Johnson & Johnson
JNJ
$613B
$539K 0.04%
5,154
-960
-16% -$97K
PFE icon
62
Pfizer
PFE
$143B
$538K 0.04%
19,114
-526
-3% -$15K
IHS
63
DELISTED
IHS INC CL-A COM STK
IHS
$527K 0.04%
3,885
-14,800
-79% -$1.85M
CLB icon
64
Core Laboratories
CLB
$491M
$521K 0.04%
3,120
-9,500
-75% -$1.69M
MMM icon
65
3M
MMM
$91.4B
$515K 0.03%
4,298
– –
IBM icon
66
IBM
IBM
$213B
$511K 0.03%
2,950
-1,203
-29% -$217K
SM icon
67
SM Energy
SM
$7.66B
$507K 0.03%
6,030
-22,500
-79% -$1.73M
MRK icon
68
Merck
MRK
$316B
$492K 0.03%
8,908
– –
SJM icon
69
J.M. Smucker
SJM
$12.6B
$490K 0.03%
4,596
– –
KMB icon
70
Kimberly-Clark
KMB
$35.7B
$484K 0.03%
4,537
– –
IPGP icon
71
IPG Photonics
IPGP
$3.7B
$479K 0.03%
6,965
-15,600
-69% -$1.05M
PG icon
72
Procter & Gamble
PG
$338B
$443K 0.03%
5,640
-500
-8% -$40.3K
GOOG icon
73
Alphabet (Google) Class C
GOOG
$4.56T
$435K 0.03%
+15,041
New +$408K
FAST icon
74
Fastenal
FAST
$55.2B
$428K 0.03%
34,560
-200
-0.6% -$2.47K
ABT icon
75
Abbott
ABT
$185B
$427K 0.03%
10,440
– –
1 2
3
4 5

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return

Conestoga Capital Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Conestoga Capital Advisors held 140 positions worth $1.49B, down 5.7% from $1.58B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors withdrew a net $54.8M in Q2 2014, closing 10 positions and reducing 71 holdings. Its most notable exit was HITTITE MICROWAVE CORP, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in Repligen worth $23.8M.

  • Conestoga Capital Advisors's largest Q2 2014 buy was Repligen: 1,044,319 shares worth $23.8M.
  • Conestoga Capital Advisors added most to Cantel Medical Corporation in Q2 2014, an estimated $15.1M increase.
  • Conestoga Capital Advisors's biggest Q2 2014 reduction was Abaxis Inc, cutting an estimated $14.2M.
  • Conestoga Capital Advisors fully exited HITTITE MICROWAVE CORP in Q2 2014, selling an estimated $26.4M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.49B portfolio in Q2 2014.
  • Conestoga Capital Advisors opened 5 new positions and closed 10 in Q2 2014.
  • Conestoga Capital Advisors's portfolio value fell 5.7% quarter-over-quarter to $1.49B.

Based on Conestoga Capital Advisors's 13F filing for Q2 2014, filed 8 Jul 2014.